Proposal of metagenomic-origin LRA-5 as a precursor of active β-lactamases through Tyr69Gln and Val166Glu amino acid substitutions: a functional and structural analysis
Wild-type LRA-5, recovered from Alaskan soil samples, shares no more than 33% amino acid sequence identity with enzymes from pathogens like PER β-lactamases. Recombinant <i>E. coli</i> expressing wild-type LRA-5 and its engineered variants LRA-5<sup>Y69Q</sup> and LRA-5<sup>V166E</sup> showed MIC values equivalent to control strains. However, LRA-5<sup>Y69Q/V166E</sup> displayed MICs above the resistant breakpoint for some β-lactams. Kinetic parameters correlated with the MICs, showing that the catalytic efficiency of LRA-5<sup>Y69Q/V166E</sup> was comparable to those from class A β-lactamases, such as CTX-M-15, PER-2, and KPC-2. LRA-5<sup>Y69Q/V166E</sup> exhibited <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> values up to 11,000-fold higher compared to wild-type LRA-5, which is associated with the presence of Glu166. The X-ray crystallographic structure of wild-type LRA-5 (1.80 Å; PDB 8EO5) shows that the lack of both Glu166 and a deacylation water molecule contributes to a biologically insignificant activity. Interactions observed between LRA-5 and ceftazidime (2.35 Å; PDB 8EO6) show structural conservation with other β-lactamases. In contrast, the crystallographic structure of LRA-5<sup>Y69Q/V166E</sup> (2.15 Å; PDB 8EO7) bears a deacylation water molecule that is associated with the increase in catalytic activity compared to the wild-type variant. Circular dichroism results confirm that amino acid substitutions in LRA-5 do not affect the overall content of the secondary/tertiary structures. Evidence suggests that alternative evolutionary paths could have occurred for β-lactamases like LRA-5, produced by environmental microorganisms: (i) proteins having similar structural features than active β-lactamases may accumulate a small number of mutations (e.g., Y69Q/V166E) to yield active enzymes and (ii) the β-lactamase fold may have lost key residues in the absence of antibiotics.
Authors
- Gabriel Gutkind (ORCID: https://orcid.org/0000-0003-1999-9785)
- Guillermo González (ORCID: https://orcid.org/0000-0002-4291-528X)
- Bárbara Ghiglione (ORCID: https://orcid.org/0000-0002-1723-5135)
- P.P. Power (ORCID: https://orcid.org/0000-0002-7051-9954)
- Shozeb M Haider (ORCID: https://orcid.org/0000-0003-2650-2925)
- Pedro Penzotti
- Sebastián Klinke (ORCID: https://orcid.org/0000-0002-8777-0870)
- Florencia Brunetti
- Luke A. Moe (ORCID: https://orcid.org/0000-0001-6864-4660)
- R.A. Powers (ORCID: https://orcid.org/0000-0002-9968-8284)
- Daniela Centrón (ORCID: https://orcid.org/0000-0001-9308-3762)
- Lin Gao (ORCID: https://orcid.org/0000-0002-7016-4612)
- M.M. Rodríguez (ORCID: https://orcid.org/0000-0001-7507-5443)
Institutions
- University of Kentucky (US)
- Universidad de Buenos Aires (AR)
- University College Lahore (PK)
- Fundación Instituto Leloir (AR)
- Centro Científico Tecnológico - Tucumán (AR)
- Instituto de Química y Fisicoquímica Biológicas (AR)
- University of Tabuk (SA)
- Grand Valley State University (US)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1128/aac.00675-25
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00